Cumberland Pharmaceuticals Earning Date (CPIX)

USA |NASDAQ |USD

CPIX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - - $-0.00
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - - $9.06M

Cumberland Pharmaceuticals's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

CPIX Earnings Date & History Chart

CPIX Earnings & Revenue Forecast

CPIX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 0 $0.00 $0.00 $0.00

CPIX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $0.14 $0.14 $0.14

CPIX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $44.85M $44.85M $44.85M

CPIX Earnings Date & Revenue History

CPIX Earnings History

|
Show More
Show More

CPIX Revenue History

|
Show More
Show More

Cumberland Pharmaceuticals Next Earnings Date & Report

CPIX Next Earnings Date & Report Preview: Jun 2022 (FQ)

CPIX's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

Cumberland Pharmaceuticals Previous Earnings Dates & Reports

CPIX Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Cumberland Pharmaceuticals's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

CPIX Previous Earnings Date & Report Recap: Dec 2021 (FY)

Cumberland Pharmaceuticals's previous annual earnings date was Mar 8, 2022 for its fiscal year ended Dec 31, 2021.

CPIX's earnings per share (EPS) was $-0.26, missing the consensus analysts forecast of $0.00 by % , and lower than the previous year's EPS (Dec 2020) by -318.33%.

Revenues were $35.99M, better than the forecast of $35.98M by 0.00%, and down by -3.89% from previous year's revenue.

The company reported a net income of $-3.60M.

Cumberland Pharmaceuticals reported a free cash flow of $4.24M for its fiscal year, compared to $3.30M a year ago.

The company ended the fiscal year with $17.03M in total debt, a decrease of -6.45% compared to the previous year.